Cellectis (CLLS) Misses Q3 EPS by 16c

Cellectis (NASDAQ: CLLS) reported Q3 EPS of ($0.58), $0.16 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $1.88 million versus the consensus estimate of $3.58 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• ZIM Integrated Shipping Services Ltd. (ZIM) Tops Q2 EPS by 82c
• Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance